
AstraZeneca's Asian Ascent: A New Chapter for Global Pharma
The pharmaceutical industry faces a period of seismic change, with much of the movement and play taking place in Asia. AstraZeneca’s recent performance and strategic moves paint a vivid picture of this trend. The company’s annual revenues exploded by an extraordinary 21%, soaring to £43 billion ($54.1 billion). This rapid...